ClinicalTrials.Veeva

Menu
S

STAAMP Research | San Antonio, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

OPN-375
Remdesivir
Obeldesivir
dupiluMAb
Remibrutinib
DUPIXENT®
OM-85

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 10 total trials

A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing

This study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheez...

Enrolling
Wheezing Lower Respiratory Illness
Recurrent Wheezing
Drug: Placebo
Drug: OM-85

This is a Phase 3, parallel group, placebo-controlled, double-blind, confirmatory study in patients with CINDU, with an optional Open-label Extension...

Enrolling
Chronic Inducible Urticaria
Drug: Remibrutinib
Other: Placebo

This is a 16-Week Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μ...

Enrolling
Bilateral Nasal Polyposis
Drug: OPN-375

Trial sponsors

Gilead Sciences logo
O
Regeneron Pharmaceuticals logo
A
D
Novartis logo
O

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems